TZ2
A dual GIP and incretin receptor agonist studied for incretin-pathway signaling and metabolic regulation.
Research Overview
TZ2 is a synthetic 39-amino-acid peptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and incretin receptors. In research models it is studied for the combined activation of both incretin pathways and downstream effects on insulin secretion, glucose homeostasis, and energy metabolism.
Its dual-receptor mechanism is the principal distinction from single incretin agonists, making it a key reference compound in comparative incretin and metabolic-pathway research.
Specifications
| Compound | TZ2 (LY3298176) |
| Classification | Metabolic research compound |
| Molecular weight | 4,813.45 g/mol |
| Sequence / Form | Synthetic 39-aa dual-incretin agonist |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
